11,857 Shares in Astera Labs, Inc. $ALAB Purchased by Nordea Investment Management AB

Nordea Investment Management AB bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 11,857 shares of the company’s stock, valued at approximately $2,028,000.

A number of other institutional investors have also added to or reduced their stakes in ALAB. Vanguard Group Inc. lifted its position in shares of Astera Labs by 14.1% in the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares during the period. State Street Corp increased its holdings in Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after buying an additional 195,992 shares during the period. 1832 Asset Management L.P. increased its holdings in Astera Labs by 151.4% during the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA raised its stake in Astera Labs by 46.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after buying an additional 479,360 shares in the last quarter. Finally, Amundi raised its stake in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 1.0%

Shares of ALAB stock opened at $112.47 on Friday. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The business’s fifty day simple moving average is $138.30 and its 200-day simple moving average is $163.37. The company has a market cap of $19.26 billion, a PE ratio of 92.19, a PEG ratio of 2.21 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the firm earned $0.37 EPS. The business’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In other Astera Labs news, Director Jack R. Lazar sold 2,500 shares of the firm’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $130.00, for a total value of $325,000.00. Following the completion of the sale, the director owned 84,851 shares of the company’s stock, valued at approximately $11,030,630. This trade represents a 2.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the sale, the chief operating officer owned 1,531,301 shares in the company, valued at $189,590,376.81. The trade was a 5.84% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 384,292 shares of company stock valued at $48,724,919. 12.50% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ALAB shares. Royal Bank Of Canada assumed coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Morgan Stanley reissued an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Northland Securities upped their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Citigroup dropped their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, February 11th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, December 3rd. Fifteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $202.22.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.